Inventor · disambiguated record
Barbara Czako
Also filed as: CZAKO BARBARA
16 granted patents·7 pending applications·95 citations·filing 2010–2024
93Inventor score
Files withUNIV TEXAS14NAVIRE PHARMA INC3BOARD OF REGENTS UNIV OF TEXAS SYSTEM2INST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT2COREY ELIAS JAMES1
Top patents by PatentIndex Score
23 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0395US10280171B2Heterocyclic inhibitors of PTPN11UNIV TEXAS·Filed 2017·Granted May 7, 2019·24 cites·37 claims
- 0494US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0593US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0692US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 0787US11104675B2PTPN11 inhibitorsNAVIRE PHARMA INC·Filed 2019·Granted Aug 31, 2021·6 cites·24 claims
- 0886US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0984US10851110B2Heterocyclic inhibitors of PTPN11UNIV TEXAS·Filed 2019·Granted Dec 1, 2020·4 cites·20 claims
- 1083US9481692B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted Nov 1, 2016·4 cites·10 claims
- 1182US10208059B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Feb 19, 2019·3 cites·6 claims
- 1280US11001594B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2018·Granted May 11, 2021·1 cites·12 claims
- 1380US9018380B2Heterocyclic modulators of HIF activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Granted Apr 28, 2015·7 cites·10 claims
- 1480US2025188074A1Ptpn11 inhibitorsNAVIRE PHARMA INC·Filed 2024·Application pending·0 cites
- 1574US11945815B2PTPN11 inhibitorsNAVIRE PHARMA INC·Filed 2021·Granted Apr 2, 2024·0 cites·16 claims
- 1674US11840536B2Heterocyclic inhibitors of PTPN11UNIV TEXAS·Filed 2022·Granted Dec 12, 2023·0 cites·18 claims
- 1774US10363261B2Enolase inhibitors and methods of treatment therewithUNIV TEXAS·Filed 2016·Granted Jul 30, 2019·2 cites·19 claims
- 1863US2024043384A1Inhibitors of pu.1 for the treatment of diseaseUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1962US2023145868A1Urea inhibitors of micro-rnaUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2052US11466017B2Heterocyclic inhibitors of PTPN11UNIV TEXAS·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 2145US2014073634A1Heterocyclic modulators of hif activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Application pending·0 cites
- 2231US2012264735A1Tyrosine kinase inhibitorsYOUNG JONATHAN·Filed 2010·Application pending·0 cites
- 2325US2012190659A1Angiogenesis inhibitorsCOREY ELIAS JAMES·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barbara Czako files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →